Search Within

Gynecologic Medicine Service

Formats
  1. Journal Article (1104)
  2. Meeting Abstract (902)
  3. Review (55)
  4. Book Section (46)
  5. Editorial (36)
  6. Guidelines (22)
  7. Correspondence (9)
  8. Miscellaneous (3)
  9. Research Letter (2)
  10. Book Whole (1)
Groups
  1. Solid Tumor Oncology Division (2180)
  2. Department of Medicine (2174)
  3. Gynecology Disease Management Team (1877)
  4. GDMT, Medicine (1859)
  5. Surgery (603)
  6. GDMT, Surgery (479)

More Groups

People
  1. Carol Aghajanian (615)
  2. Nadeem Abu-Rustum (292)
  3. Martee Hensley (290)
  4. Roisin O'Cearbhaill (273)
  5. Vicky Makker (269)
  6. Paul Sabbatini (262)

More People

Years
  1. 2025 (75)
  2. 2024 (167)
  3. 2023 (171)
  4. 2022 (209)
  5. 2021 (163)
  6. 2020 (203)

More Years

Publications
  1. Journal of Clinical Oncology (458)
  2. Gynecologic Oncology (420)
  3. International Journal of Gynecological Cancer (161)
  4. Annals of Oncology (117)
  5. Clinical Cancer Research (71)
  6. Cancer Research (55)

More Publications

Publishers
  1. American Society of Clinical Oncology (498)
  2. Elsevier B.V. (446)
  3. Lippincott Williams & Wilkins (188)
  4. American Association for Cancer Research (173)
  5. Oxford University Press (144)
  6. Elsevier Inc. (128)

More Publishers

Results (2180)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • FORWARD I (GOG 3011): A phase III study of mirvetuximab soravtansine, a folate receptor alpha (FRa)-targeting antibody-drug conjugate (ADC), versus chemotherapy in patients (pts) with platinum-resistant ovarian cancer (PROC)
    Meeting Abstract

    Moore, K.; Oza, A.; Colombo, N.; Oaknin, A.; Scambia, G.; Lorusso, D.; Farias-Eisner, R.; Banerjee, S.; Murphy, C.; Tanyi, J.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Effect of response to last platinum-based chemotherapy in patients (pts) with platinum-sensitive, recurrent ovarian carcinoma in the phase III study ARIEL3 of rucaparib maintenance treatment
    Meeting Abstract

    Ledermann, J. A.; Oza, A. M.; Lorusso, D.; Aghajanian, C.; Oaknin, A.; Dean, A.; Colombo, N.; Weberpals, J. I.; Clamp, A. R.; Scambia, G.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • ENGOT-EN9/LEAP-001: A phase III, randomized, open-label study of pembrolizumab plus lenvatinib versus chemotherapy for first-line treatment of advanced or recurrent endometrial cancer
    Meeting Abstract

    Marth, C.; Vulsteke, C.; Rubio, M. J.; Makker, V.; Braicu, E. I.; McNeish, I. A.; Radoslaw, M.; Ayhan, A.; Hasegawa, K.; Wu, X.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Patient-centred outcomes with maintenance olaparib in newly diagnosed patients with advanced ovarian cancer (OC) and a BRCA mutation (BRCAm) in the phase III SOLO1 trial to support the clinical benefit of prolongation of progression-free survival (PFS)
    Meeting Abstract

    Friedlander, M. L.; Moore, K.; Colombo, N.; Scambia, G.; Kim, B. G.; Oaknin, A.; Lisyanskaya, A.; Floquet, A.; Leary, A.; Sonke, G. S.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Randomized, phase Ib/II study of M6620 + avelumab + carboplatin vs standard care (sc) in patients (pts) with platinum-sensitive poly (ADP-ribose) polymerase inhibitor-(PARPi)-resistant ovarian cancer
    Meeting Abstract

    Banerjee, S.; Vergotte, I.; Colombo, N.; Barve, M.; Grisham, R.; Mehr, K. T.; Falk, M.; Beier, F.; Hennessy, M.; Schroeder, A.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Phase I dose escalation of MSC-1, a humanized anti-LIF monoclonal antibody, in patients (pts) with advanced solid tumours: Updated results
    Meeting Abstract

    Borazanci, E.; Schram, A.; Brana, I.; Vieito Villar, M.; Garralda, E.; Spreafico, A.; Oliva, M.; Lakhani, N.; Wasserman, R.; Hoffman, K.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Immunomodulatory drugs encoded by oncolytic viruses: Is the whole greater than the sum?
    Editorial

    Zamarin, D.
    Molecular Therapy (2019)

    Fulltext@MSK | Save
  • Toward automation of germline variant curation in clinical cancer genetics
    Journal Article

    Ravichandran, V.; Shameer, Z.; Kemel, Y.; Walsh, M.; Cadoo, K.; Lipkin, S.; Mandelker, D.; Zhang, L.; Stadler, Z.; Robson, M.; more...
    Genetics in Medicine (2019)

    Fulltext@MSK | Save
  • The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer
    Journal Article

    Figlioli, G.; Bogliolo, M.; Catucci, I.; Caleca, L.; Lasheras, S. V.; Pujol, R.; Kiiski, J. I.; Muranen, T. A.; Barnes, D. R.; Dennis, J.; more...
    npj Breast Cancer (2019)

    Fulltext@MSK | Save
  • Modeling accrual of older adults to cancer clinical trials: (Alliance A151736)
    Meeting Abstract

    VanderWalde, N. A.; Wakefield, D. V.; Satele, D. V.; Dockter, T.; Sloan, J. A.; Jagsi, R.; Lichtman, S. M.; Freedman, R. A.; Lafky, J. M.; Muss, H. B.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save